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Abstract
Infection with hepatitis B virus (HBV) has been detected in human populations thoughout the world, as well as in a number of ape species
(Pan troglodytes, Gorilla gorilla, gibbons [Nomascus and Hylobates species] and Pongo pygmaeus). To investigate the distribution of
naturally occurring HBV infection in these species and other African Old World monkey species (Cercopithecidae), we screened 137 plasma
samples from mainly wild caught animals by polymerase chain reaction (PCR) using several of highly conserved primers from the HB
surface (HBs) gene, and for HBs antigen (HBsAg) by ELISA. None of the 93 Cercopithecidae screened (6 species) showed PCR or serology
evidence for HBV infection; in contrast 2 from 8 chimpanzees and 5 from 22 gibbons were PCR-positive with each set of primers.
Complete genome sequences from each of the positive apes were obtained and compared with all previously published complete and
surface gene sequences. This extended phylogenetic analysis indicated that HBV variants from orangutans were interspersed by with HBV
variants from southerly distributed gibbon species (H. agilis and H. moloch) occupying overlapping or adjacent habitat ranges with
orangutans; in contrast, HBV variants from gibbon species in mainland Asia were phylogenetically distinct. A geographical rather than
(sub)species association of HBV would account for the distribution of HBV variants in different subspecies of chimpanzees in Africa, and
explain the inlier position of the previously described lowland gorilla sequence in the chimpanzee clade. These new findings have a number
of implication for understanding the origins and epidemiology of HBV infection in non-human primates.
© 2003 Elsevier Inc. All rights reserved.
Introduction
Infection with hepatitis B virus (HBV) is a major global
health problem, and is estimated to account for approxi-
mately one million deaths from chronic liver disease and
hepatocellular carcinoma each year (Thomas and Jacyna,
1993). High frequencies of active infection, ranging from
8–15% are found in South and East Asia, sub-Saharan
Africa and amongst indigenous peoples in Central and
South America (Andre, 2000). In Asia this endemic pattern
of HBV infection is primarily maintained through mother-
to-child perinatal transmission and establishment of a highly
infectious carrier state that transmits infection to the next
generation. In contrast, horizontal transmission is the pre-
dominant mechanism in Africa.
Although HBV (classified as a member of the Hepad-
naviridae) contains a DNA genome, replication occurs
through an RNA intermediate sequence analogous to the
genomic RNA sequence of retroviruses. The copying of
DNA from sequences from genomic DNA templates, and
from the intermediate RNA transcript, is carried out by a
virally encoded polymerase protein. The lack of proof-
reading during viral transcription introduces a high fre-
quency of mutations into the copied sequences (Hannoun
et al., 2000). Indeed, HBV populations are characterized
by a moderate degree of genetic diversity, with a total of
8 currently classified genotypes infecting human popula-
tions worldwide, differing from each other by nucleotide
sequence distances of approximately 10 –13%. Geno-
types A, D and possibly G have global distributions,
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genotypes B and C are found predominantly in East and
South East Asia, genotype E in West Africa, and geno-
types F and H amongst various population groups, in-
cluding indigenous peoples, in Central and South Amer-
ica (Norder et al., 1994; Arauz-Ruiz et al., 1997; Arauz-
Ruiz et al., 2002).
Recently, we (MacDonald et al., 2000) and others
(Takahashi et al., 2000; Hu et al., 2000; Vartanian et al.,
2002; Hu et al., 2001) have documented the existence of
HBV infection in chimpanzees in the wild, findings
which add to other descriptions of frequent infection of
gibbons and orangutans in South East Asia (Warren et al.,
1999; Grethe et al., 2000; Verschoor et al., 2001; Nop-
pornpanth et al., 2003). Nucleotide sequencing of HBV
recovered from these ape species revealed the existence
of new genotypes of HBV generally specific to each
species, although with some exceptions, such as the de-
tection of a human genotype E variant in a captive chim-
panzee (Takahashi et al., 2000), the close relatedness of
HBV recovered from a lowland gorilla to chimpanzee
sequences (Grethe et al., 2000), and the detection of a
gibbon-like HBV sequence in a captive chimpanzee (Gre-
the et al., 2000).
Apart from humans and non-human primates, far more
divergent HBV-like viruses have been detected in New
World rodents such as the woodchuck (Marmota monax),
and squirrel species (Spermophilus beecheyi, S. parryii),
and a range of bird species (ducks, geese, and grey
heron). The evolutionary history of HBV in these various
host species has been the subject of great debate over the
past 5 years, principally fueled by the difficulty in rec-
onciling the frequently interspersed genotype distribu-
tions of human and non-human primate sequences that
seems to fit neither hypothesis for very recent or very
ancient origins for HBV (Magnius and Norder, 1995;
Norder et al., 1994; MacDonald et al., 2000) [reviewed in
(Simmonds, 2001)]. In the current study, we have at-
tempted to discover more about the distribution of HBV
infection in apes and Old World monkey species (Cer-
copithecidae) using a large archive of stored serum and
plasma samples from a wide range of different African
and South East Asian primate species. Combining the
new data obtained in this study with recently published
sequences from gibbons, orangutans and chimpanzees
(Vaudin et al., 1988; MacDonald et al., 2000; Takahashi
et al., 2000; Hu et al., 2000; Hu et al., 2001; Warren et
al., 1999; Grethe et al., 2000; Verschoor et al., 2001;
Noppornpanth et al., 2003; Takahashi et al., 2001;
Vartanian et al., 2002), we have been able to carry out
comprehensive genetic comparisons of the expanded
dataset of primate and human-derived HBV variants that
indicates that geographical separation in primates ex-
plains genotype distributions of HBV better than species
associations.
Results
Detection of HBV infection in non-human primates
To determine the frequency of active HBV infection in
Apes and Old World primate species, we screened available
plasma or serum samples collected from a range of species
by PCR using previously described primers from the pre-S
and S region (S1, S2). All samples had been screened for
HBsAg by commercially available ELISAs. The pre-S and
S primers were conserved between human genotypes A–G,
the more divergent F and H genotypes, and all published
HBV sequences recovered from non-human primates in-
cluding the HBV variant obtained from New World woolly
monkey species (Fig. 1A and B).
Results from the two sets of primers were concordant
with each other and with the results of HBsAg screening
with the exception of 1 HBsAg positive chimpanzee that
was DNA negative. The frequency of detection of active
HBV infection depended on the host species. Within the
apes, we detected 2 HBV-positive samples from the 8 chim-
panzees screened, 5 from the 22 gibbons species, and none
from 14 orangutans (total prevalence of active infection in
apes: 7/44 [15.9%]). In contrast, none of the 93 samples
available from a total of 6 Old World Monkey species were
positive in either PCR assay, nor confirmed positive for
HBsAg. The observed restriction of HBV injection to apes
and the frequency of active infection found in this study was
consistent with previous surveys of HBV infection in pri-
mates (Table 1; see Discussion). Further evidence for a lack
of HBV infection in these samples of Old World monkey
species was provided by the lack of detectable antibodies to
the HBV core protein (anti-HBc), used diagnostically as an
indication of past resolved infection in samples negative for
HBsAg.
Previous studies have demonstrated that non-human pri-
mates are generally infected with species-specific genotypes
of HBV (Vaudin et al., 1988; MacDonald et al., 2000;
Takahashi et al., 2000; Hu et al., 2000; Hu et al., 2001;
Warren et al., 1999; Grethe et al., 2000; Verschoor et al.,
2001; Noppornpanth et al., 2003; Takahashi et al., 2001;
Vartanian et al., 2002). Therefore, one explanation for the
apparent absence of HBV infection in Old World monkey
species is that the putative variants of HBV perhaps present
in these more evolutionarily distant species may be too
divergent to be detectable by conventional HBV primers
and hence too different antigenically to be detectable by
conventional HBsAg or anti-HBc screening. To investigate
this possibility, we developed a new set of primers (S3)
from a highly conserved region of the surface gene that
matched not only all human and non-human primate HBV
variants, but also the sequences of each of the HBV-like
viruses recovered from rodents (ground and arctic squirrels,
woodchuck; Fig. 1C). The new primers showed equivalent
sensitivity for human and primate HBV sequences as the S1
and S2 primers for human and primate genotypes of HBV
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(data not shown). However, screening of this sample of Old
World primate species failed to detect any additional cases
of HBV infection (Table 1).
Species and sub-species identification of HBV-infected
apes
Of the two chimpanzees positive for HBV DNA, one
(Osang) originated from Central Africa and its subspecies
identification as P. troglodytes vellerosus was determined
by mitochondrial sequencing. The other infected chimpan-
zee (Louisa) originated from Cameroon and belonged to the
troglodytes subspecies. The infected gibbons belonged to
species H. lar (Tamang), H. agilis (Crazy Woman), N.
concolor (Happy) and N. gabriellae (Wendy). This species
information was provided by the Welsh Mountain Zoo and
the rescue centre respectively. It was not possible to obtain
a species assignment for the final HBV-infected gibbon
analyzed in the study (TB Black), although it was possible
to identify it as belonging to the Hylobates genus and most
likely belonging to the agilis or moloch subspecies as Mi-
tochondrial 12S region sequences for these species were
interspersed when compared phylogenetically (data not
shown).
Sequence comparison of HBV sequences from non-human
primates
Sequence relationships between the 7 (from 44) ape
samples positive for HBV DNA by PCR with previously
Fig. 1. Sequence conservation of HBV and HBV-like virus sequences from primates and rodents in regions of the genome targeted by S1, S2 and S3 primer
sets used for PCR. Primer sequences were compared with consensus sequences from the human HBV genotypes A–H (H–A to H–H), consensus sequences
from chimpanzee, gibbon, orangutan (CH, GN, OT), and the woolly monkey sequence (WM). The lower panel for each alignment contains HBV-like virus
sequences from North American rodent species, ground squirrel (GS), arctic ground squirrel (AGS) and woodchuck (WC, OHVCGC). For each alignment,
differences from the consensus genotype A sequence was shown; primer sequences included degenerate bases (represented by the codes: M: A/C; Y: C/T;
R: A/G; K: G/T) in variable regions. Alignment numberings refer to a minimal alignment of human and primate derived HBV sequences listed in the Methods
section.
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described variants of HBV from human and non-human
primates were investigated by determination of their com-
plete genome sequences and phylogenetic analysis. HBV
variants included in the analysis comprised all previously
published full length HBV sequences from non-human pri-
mates and 10 representative sequences from each of the
human genotypes A–H. The maximum likelihood tree of
these data provided bootstrap support for each human ge-
notype and primate-associated species, with the exception
of gibbon and orangutan sequences (Fig. 2). However, other
than the close relationships between genotypes D and E, and
F and H, there was little support for any other inter-clade
relationship. A separate comparison of S gene sequences
was also carried out to enable several further partial
genomic sequences from primates to be included in the
analysis (Fig. 3; see below).
Chimpanzee sequences
Both complete genome and surface gene sequences from
the two HBV-infected chimpanzees (Louisa, Osang)
grouped consistently with other previously published se-
quences (Fig. 2 and 3A). This together with the handling
and testing history is consistent with infection in the wild.
Within the divergent clade of chimpanzee sequences, indi-
vidual sequences fell into a variety of groups, with a strong
association with subspecies and/or geographical origin (Fig.
4A). For example, clusters were observed corresponding to
verus subspecies from West Africa (whole genome se-
quences AB032433, HPBVCG, AB032432, AB032433,
AF222323 and Chimp 4), troglodytes from Central Africa
(AF222322, Chimp 2 and Louisa), vellerous from Central-
West Africa (Osang, AF305327), and a separate clade for
Table 1
Frequencies of detection of HBV DNA sequences, HBsAg and anti-HBc in current and previous studies of primates
Species PCR* Total Active‡
infection (%)
anti-HBc Reference
S1/S2 S3 PCR† HBsAg
APES
Gorilla gorilla spp. — — 7/18 2/15 7/18 (39%) — (Grethe et al., 2000; Zuckerman et al., 1978;
Linnermann, Jr. et al., 1984; Thornton et al., 2001;
Worley and Stalis, 2002)
Pan troglodytes spp. 2/8 — 28/38 38/496 54/517 (10.5%) 2/6 This study, (Takahashi et al., 2000;
MacDonald et al., 2000; Hu et al., 2000;
Takahashi et al., 2001; Hu et al., 2001;
Grethe et al., 2000; Zuckerman et al., 1978)
(Vaudin et al., 1988) (Deinhardt, 1976;
Ogata et al., 1993; Eichberg and Kalter, 1980)
Hylobates spp. 5/22 — 53/177 35/191 55/213 (25.8%) 48/130 This study, (Grethe et al., 2000; Norder et al., 1996;
Lanford et al., 2000; Vaudin et al., 1988;
Deinhardt, 1976; Thornton et al., 2001;
Noppornpanth et al., 2003)
Pongo pygmaeus spp. 0/14 — 32/104 58/141 58/297 (19.5%) 1/14 This study, (Warren et al., 1999; Davis et al., 2000;
Vaudin et al., 1988; Deinhardt, 1976)
Total Apes 7/45 — 120/337 133/843 174/1045 (16.7%) 51/150
OLD WORLD MONKEYS
Papio spp. — — 0/4 0/168 0 0/103 (Deinhardt, 1976; Michaels et al., 1996;
Eichberg and Kalter, 1980)
Cercopithecus aetiops — — — 0/19 0 — (Eichberg and Kalter, 1980)
Cercopithecus torquatus 0/4 0/4 0/4 0/4 0 0/4 This study
Cebus albifrons — — — 0/10 0 — (Eichberg and Kalter, 1980)
C. mona 0/3 0/3 0/3 0/3 0 0/3 This study
C. nictitans 0/2 0/2 0/2 0/2 0 0/2 This study
C. erythrotis 0/3 0/3 0/3 0/3 0 0/3 This study
Mandrillus leucophaeus 0/78 0/78 0/78 0/78 0 0/78 This study
M. sphinx 0/2 0/2 0/2 0/2 0 0/2 This study
Total OWM 0/102 0/102 0/96 0/289 0 0/195
NEW WORLD MONKEYS
Lagothrix lagotricha — — 10/35 7/31 10/33 — (Lanford et al., 1998)
Saimiri sciureus — — — 0/20 0 — (Eichberg and Kalter, 1980)
Callithrix jacchus — — — 0/6 0 — (Eichberg and Kalter, 1980)
Saguinus oedipus — — — 0/12 0 — (Eichberg and Kalter, 1980)
Total NWM — — 10/58 7/69 10/33 (30%) —
* PCR results from pre-S and S gene primers (S1, S2), and from highly conserved primers (S3; Fig. 1C) from this study.
† Combined PCR results from current survey and from previous studies (cited in last column).
‡ Combined results for PCR-positivity and detection of HBsAg indicating active HBV infection.
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the single Schweinfurthii (East African) HBV variant
(AF498266). The only sequence that failed to group within
its sub-species group was AB046525 obtained from a cen-
tral African troglodytes species; this may be because it
contains an unusual core gene sequence thought to have
originated through recombination with a highly divergent
and hitherto undiscovered entirely separate genotype of
HBV (Takahashi et al., 2001) (see below). Similar grouping
of sequences into subspecies- or geographically-associated
clades was found on analysis of partial S gene sequences.
Fig. 2. Maximum likelihood phylogenetic tree for 99 complete HBV genomes (3342 bp) representing human genotypes A to H and all ape HBV sequences
with the single woolly monkey HBV sequence as an outgroup. Neighbor-Joining bootstrap values (75%) for major groupings are indicated on the relevant
nodes. All horizontal branch lengths are drawn to scale.
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Finally, the single available sequence from the gorilla
(HBV131567) fell into its own unique clade within the chim-
panzee genotype, an unexpected position if it is assumed that
HBV variants are species (and sub-species)-specific, but not
inconsistent with the alternative hypothesis for a geographical
basis for the observed sequence groups. As indicated (Fig. 4A),
western lowland gorillas share their geographical range with
the troglodytes subspecies of chimpanzee in Central Africa.
Fig. 3. Maximum likelihood phylogenetic trees of partial S gene sequences (689 bp) from (A) chimpanzees and (B) gibbons and orangutans. The chimpanzee
tree is rooted using a single gibbon sequence (Tamang) and the gibbon/orangutan tree is rooted using a chimpanzee sequence (Osang). Neighbor-Joining
bootstrap values (75%) for major groupings are indicated on the relevant nodes. All horizontal branch lengths are drawn to scale.
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Fig. 4. Distribution of (A) chimpanzee subspecies and lowland gorillas in Africa, and (B) species of gibbons and orangutans in South East Asia.
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Interestingly, the gorilla-derived sequence groups most closely
with HBV sequences from this subspecies on comparison of
complete genome sequences (Fig. 2), although this similarity
does not lead to a bootstrap supported G. gorilla/P.t.trogl-
odytes clade, nor is this similarity apparent upon sequence
comparison of the surface gene fragment (Fig. 3A).
Gibbon sequences
Complete genome sequences from 5 gibbons were ob-
tained and compared with the 12 previously published HBV
sequences from gibbon species and with those from two
orangutans, and the single chimpanzee sequence (Fig. 2). As
with the chimpanzee sequences, there was evidence for
marked clustering of HBV sequences according to their host
species, although the total sequence divergence within the
clade was greater than found amongst the chimpanzee sub-
species, and much greater than within human genotypes.
There was also greater lineage differentiation within the
gibbon sequence group, including well defined sequence
clusters of sequences from H. lar, nomascus species (N.
concolor, leucogenys and gabriellae) and from H. pileatus
and a series of divergent single sequences, including those
from Happy, TBBlack and CrazyWoman obtained in the
current study. Lack of strict species-specificity of HBV
variants was demonstrated in the S gene fragment by
the highly divergent sequences obtained from H. moloch
and agilis (CrazyWoman, AF213010, AF213008 and
AF213009), the relation of an HBV variant from N. con-
color (HBV131573) with these sequences and its failure to
group with the main clade of concolor sequences (Fig. 3).
Other anomalies include the outlier positions of the H.
pileatus variant (AF477488) and the highly divergent se-
quence we obtained from Happy (N. gabriellae).
If a broader division of gibbon species into the hylobates
(moloch, agilis, pileatus and lar species) and nomascus
(concolor, leucogenys and gabriellae species) genera is
made, there is still no association between host and HBV
phylogeny. However, the greatest discordance between
HBV grouping and species of origin is demonstrated by the
phylogenetic position of the HBV sequences obtained from
orangutans. The two complete genome sequences
(NC_002168 and AF193864), and the further 5 partial S
gene sequences (HBVY17559–HBVY17565) grouped
closely together, but they consistently fell within the gibbon
clade, in an analogous manner to the position of the lowland
gorilla sequence within chimpanzee sequences (see above).
A better correlation was observed between geographical
origin and/or host range of the HBV-infected species with
the phylogenetic clustering of HBV variants recovered from
them. The gibbon and orangutan sequences can be divided
into three main groups, the first of which contains orangutan
HBV variants and those infecting two of the hylobates
species, which inhabit the Southern region of SE Asia, and
overlap in range with orangutans. The second group con-
tains sequences from northerly distributed nomascus species
of gibbons and H. lar, distributed predominantly in Central
Thailand and Laos. HBV variants infecting H. pileatus, a
gibbon species inhabiting Cambodia and Central Thailand
made up the third clade of sequences.
The main inconsistency with the phylogeny of gibbon-
derived HBV sequences is the anomalous position of the
chimpanzee-derived HBV variant, HBV131575. This se-
quence groups with a number of HBV variants infecting H.
lar, including HBV131571 from the same study (Grethe et
al., 2000). This is the only case where an HBV variant
infecting a non-Asian primate groups with gibbon and or-
angutan sequences, and further information is required on
whether a cross-species transmission of HBV could have
occurred in captivity.
Discussion
Host range and epidemiology of HBV in primates
Our PCR-based and serological survey of a wide range
of Old World primate species provided further evidence for
a substantial restriction of HBV infection to apes (Table 1),
and is consistent with previous observations for the absence
of detectable HBV infection in Old World monkey species
(Deinhardt, 1976; Michaels et al., 1996; Eichberg and
Kalter, 1980). Combining data from this and previous sur-
veys, HBV infection appears to be common in all species of
apes, with combined rates of PCR-positivity and/or HBsAg
carriage of 16.7% (Table 1). This rate of active infection is
remarkably similarly to that of human populations in areas
of endemic infection, such as Central Africa and South East
Asia.
Further parallels between the epidemiology of HBV in-
fection in human and non-human primates is provided by
the evidence for efficient mother-to-child transmission of
HBV in captive primate species (Noppornpanth et al., 2003;
Lanford et al., 2000). In humans, such perinatally acquired
infections generally lead to lifelong HBV high infectivity
carriage associated with partial immunotolerance and the
production of the HBV “e” antigen (HBeAg). Persistent
infection of females perpetuates the infection cycle to each
succeeding generation. Observations of frequent vertical
transmission in captive gibbons (Noppornpanth et al., 2003)
supports the hypothesis that this may also be an important
mechanism for the maintenance of HBV infection in gib-
bons and potentially other ape species in the wild.
One explanation for the failure to detect HBV infection
in Old World monkey species is that they were infected with
HBV variants so divergent in sequence from previously
described HBV variants infecting humans and other pri-
mates that they would be refractory to amplification with
conventional primers, and be serologically non-cross-reac-
tive with reagents used in HBsAg and anti-HBc assays.
Such viruses would therefore have to be more divergent
than the outlier HBV variant found in a captive woolly
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monkey (Lanford et al., 1998). To address this issue we
re-screened the Old World monkey species by PCR using
primers that matched even the highly divergent HBV-like
viruses infecting North American rodents. Our failure to
detect a single additional case of HBV infection in the 93
African monkey samples available provided further evi-
dence for an absence of infection of hepadnaviruses in these
species of the Cercopithecidae, although it is possible that
this picture may change with more extensive sampling in a
greater range of species (see below).
Why HBV infection in the wild should be generally
restricted to apes remains unclear at this stage. Given this
highly selective distribution of HBV infection in Old World
species, the existence of HBV infection in woolly monkeys
(a New World primate species) becomes more difficult to
account for. A total of 10 infected animals have been re-
ported be HBV-infected in a US zoo, although a previous
serological survey of three other New World primate spe-
cies (owl monkey, tamarind, and squirrel monkey) have
failed to detect evidence of active of past HBV infection in
this group [Table 1; (Eichberg and Kalter, 1980)]. Clearly
further surveys would be required to determine whether
HBV infection is present in wild caught monkeys in South
America.
HBV origins
Reconstructing an evolutionary history of HBV using the
data set of sequences of HBV variants infecting humans and
other primates has proven to be both complex and difficult
to reconcile with theories of either recent or remote times of
origin (Bollyky et al., 1997; Magnius and Norder, 1995;
Norder et al., 1994; MacDonald et al., 2000; Simmonds,
2001). The new sequence information obtained in this pa-
per, and the combined analysis with the much larger dataset
of HBV sequences now available from other studies, has
provided strong evidence for a correlation between geo-
graphic origin of infection and sequence divergence that
cuts across species barriers of non-human primates. Thus,
HBV sequences from Central Africa group together, irre-
spective of their origin in chimpanzees or gorillas. A similar
picture is observed in South Eastern Asian primates where
gibbon and orangutan HBV sequences cluster together and
their host species have overlapping geographic ranges.
Understanding the epidemiology of HBV infection in
non-human primates is additionally complicated by the dif-
ficulty in constructing a time-scale for the divergence of the
current distribution of variants found in non-human species.
However, short-term rates of HBV sequence change have
been determined for HBV infecting humans, with evidence
for a higher rate of sequence change in individuals who
mount an effective immune response to infection. Based on
the HBeAg/anti-HBe status, mean frequencies of fixation of
nucleotide substitution range from 2.1 to 25  105 nucle-
otide change per site per year (Hannoun et al., 2000). As
HBeAg carriage (associated with a slower rate of sequence
change) is typically associated with early acquisition of
HBV infection from vertical transmission, a mode of trans-
mission that maintains HBV infection in human populations
and potentially in primates (Noppornpanth et al., 2003), the
sequence divergence of HBV variants infecting different
subspecies of chimpanzee can be conservatively estimated
as ranging at most from 1600 to 2200 years (mean sequence
divergence 7%; rate of sequences change 2.1  105 nu-
cleotide change per site per year). A similar time-scale for
HBV evolution was inferred using non- overlapping regions
of the HBV genome (Fares and Holmes, 2002).
The calculated time-scale of HBV evolution implied by
measurement of rates of sequence change over short inter-
vals indicates that the current wide distribution of HBV
infection in apes must have arisen through several cross-
species or subspecies transmissions in the relatively recent
past. For example, HBV transmission following limited
population contact between different ape species in South
Eastern Asia (including between orangutans and gibbons),
and between subspecies of chimpanzee and with gorillas
with Africa may have provided the necessary conditions for
both the introduction and subsequent differentiation of HBV
genetic clusters into otherwise separate host populations.
In contrast to the co-speciation hypotheses discussed
below, the recent emergence hypothesis for HBV infection
in primates resolves many of the unexpected phylogenetic
groupings evident from the comparison of the much larger
datasets of ape-derived HBV sequences (Fig. 3). Despite the
previous claim for the existence for an orangutan-specific
genotype of HBV (Warren et al., 1999; Verschoor et al.,
2001), the availability of a larger number of gibbon se-
quences, including those obtained in the current study,
clearly places orangutan-derived variants deep into the gib-
bon clade of HBV sequences. Indeed, they show the closest
genetic relationship with HBV variants infecting hylobates
species with geographically close or overlapping habitat
ranges. In contrast, HBV variants infecting H. lar and the
nomascus gibbons from mainland Asia generally group sep-
arately.
The lack of sequence diversity of HBV sequences be-
tween separate infected orangutans further suggests that the
introduction of HBV into this species may have been rela-
tively recent. Indeed, the absence of HBV infection in our
sample of 14 wild caught orangutans from Borneo suggests
that HBV infection may not be so widely distributed geo-
graphically in this species as it evidently is in gibbons, and
more consistent with recent introduction. Recent cross-spe-
cies transmission events may also account for the close
relationship between the single available gorilla-derived
HBV variants with HBV infecting the troglodytes subspe-
cies of chimpanzee whose ranges overlap in Central Africa
(Fig. 2 and 3A), although more sequence information of
HBV infecting other gorillas in the wild is required to
substantiate this further possible example of cross-species
transmission in the wild.
An alternative explanation of the distribution of non-
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human HBV genotypes in Africa and South East Asia pro-
poses that the distinct genotypes of HBV in different pri-
mate species arose during the evolution of different ape
species over the past 20 million years. However, the implied
very low rate of nucleotide substitution of HBV over these
extended periods of host diversification is incompatible with
extrapolations of the previously calculated rate of HBV
sequence change over short observation periods. For exam-
ple, while we estimate that the sequence divergence of HBV
infecting different subspecies of chimpanzees arose
1600–2200 years ago, the times of host species diver-
gence range from 0.8 million years for the divergence be-
tween subspecies of chimpanzees from Central Africa (trog-
lodytes, vellerosus and schweinfurthii subspecies) and an
estimated 1.5 million years between these subspecies and
P.t. verus from West Africa (Morin et al., 1994). Similarly,
extrapolating from the above rates of sequence change, the
radiation of gibbon- and orangutan-associated HBV variants
can be timed as no more than 3500 years, a time-scale
difficult to equate with the species and/or geographic dif-
ferentiation of HBV variants in the wide range of primates
infected with HBV.
In defence of the co-speciation hypothesis, it could be
argued that constraints on sequence change, such as the
unusual and extensive use of overlapping reading fames for
protein coding in the HBV genome, as well as the role of
RNA structures in transcription and translation (Mizokami
et al., 1997) may prevent the simple and relatively uncon-
strained fixation of neutral mutations. For example, the
absence of true synonymous sites in over 65% of the ge-
nome through the use overlapping reading frames, and the
existence of cis-acting RNA structures required for HBV
transcription and translation may lead to a rapid saturation
of sequence substitutions and homoplasy in the (relatively
few) phenotypically unconstrained sites, although low rates
of divergence were also observed in non-overlapping re-
gions of the HBV genome (Fares and Holmes, 2002). The
loss of the variable, phylogenetically informative sites
through homoplasy would therefore explain the instability
of any sequence grouping of HBV variants below the level
of (human) genotype or of non-human primate genetic
groupings. More importantly, extensive homoplasy would
prevent the extrapolation of the short term rate of sequence
change of HBV (over 10 years) to the longer periods un-
derlying the differentiation of HBV into separate genotypes.
However, no permutation of the co-speciation hypothesis
can explain the inlier position of orangutan-derived HBV
variants within the clade containing gibbon sequences (Fig.
2 and 3B), or the anomalous position of the lowland gorilla
HBV sequence in the chimpanzee HBV phylogeny. Even
more seriously, it fails to account for the substantial se-
quence diversity of HBV variants infecting humans. While
it might be possible to compress human genotypes A to E
and G into a single group that reproduces the diversity of
HBV sequences found in gibbons (and orangutans), this
approach cannot account for the outlier position of geno-
types F and H. Nor can the diversity of HBV variants
infecting humans, with a maximum population age of
150,000 years (Stringer, 2002), be reconciled with the much
more restricted sequence diversity of HBV variants infect-
ing the several subspecies of chimpanzee which diverged
over a time-scale 10 times greater, or different species of
gibbon that diverged even longer ago.
Secondly, the hypothetical restrictions on sequence di-
vergence can not explain how HBV-like viruses infecting
rodents and birds have become so divergent from human
and primate HBV variants over maximum chronological
times of 100 to 300 million years. Even against the yardstick
of these much longer periods for sequence diversification,
greater sequence divergence and an outlier position for
gibbon-derived HBV sequences would be expected to be
resolvable over the 15 million years of ape diversification.
In summary, the proposed scenario for the relatively
recent spread of HBV among African and South East Asian
primates and cross-species transmission between animals in
adjacent or overlapping ranges accounts much better for the
geographical rather than the species association of HBV
genotypes in non-human primates than previous co-specia-
tion theories (Magnius and Norder, 1995; Norder et al.,
1994; MacDonald et al., 2000). However, while the trans-
mission networks of HBV in Africa and South East Asia are
clearly separate, one difficult remaining question is how
HBV could have spread between the African, Asian and
potentially South American continents in the previous few
thousand years. Resolving this question will require a better
understanding of the relationship between human and non-
human primate HBV variants, and the potential role of
humans in disseminating HBV infection over these much
larger geographical distances in the more remote past.
HBV divergence
Current and previous studies of HBV genotype distribu-
tions in apes have demonstrated the existence of HBV
variants with relatively limited sequence diversity, mani-
fested in particular by the grouping of these variants inter-
spersed with the human genotypes A–E and G (Fig. 2).
There is no evidence so far for HBV variants in apes as
divergent as the human genotypes F and H, nor the HBV
variant obtained from a captive woolly monkey.
However, the core gene sequence of the HBV variant,
AB046525, recovered from a P.t. troglodytes subspecies in
Central Africa (Takahashi et al., 2001) is highly divergent
from equivalent regions in other HBV variants obtained
from chimpanzees, other apes or humans, and indeed is as
divergent from viruses in these latter species as the woolly
monkey sequence (Lanford et al., 1998). Strangely the rest
of the genome of AB046525 groups with HBV variants
recovered from the troglodytes subspecies of chimpanzees
(eg., in the S gene; Fig. 3B). As previously suggested, this
virus is likely to be a recombinant between a troglodytes-
associated HBV variant and another highly divergent HBV
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variant of unknown origin. Combined with the woolly mon-
key variant (again of obscure origin), these findings hint
towards the existence of much more divergent HBV vari-
ants in nature that are refractory to current primate surveil-
lance methods. Further work to discover the original species
distribution of such variants will provide considerable in-
sights into the ultimate origins and evolution of HBV in
primates, and may help to resolve the many conflicting
theories for the origin and past epidemiology of HBV in-
fection in human populations.
Materials and methods
Primate samples
A total of 137 primate serum and plasma samples were
available for screening. From Africa, samples from 71 drills
(Mandrillus leucophaeus) were available from a rescue cen-
tre in Nigeria; in the study population, 48 were wild-born
and 23 captive-born; all samples were negative for HBV
surface antigen (HBsAg). A total of 14 samples were avail-
able from 8 drills, 2 mandrills (Mandrillus sphinx), 4
cherry-capped mangabeys (Cercopithecus torquatus) kept
at the Limbe Wildlife Center in Cameroon, all of which
were wild-born. From the same centre, a total of 7 samples
from chimpanzees were also available, of which 2 were
HBsAg positive, 3 were negative and 2 were unknown.
Finally, one sample from a known HBsAg positive chim-
panzee and 3 HBsAg-negative samples from mona monkeys
(Cercopithecus mona), 2 samples from putty-nosed mon-
keys (C. nictitans) and 3 samples from red-eared monkeys
(C. erythrotis) were provided for the study from a rescue
centre in Nigeria.
From South East Asia, 20 gibbon samples from various
wild-born gibbon species (Hylobates spp.; 4 HBsAg posi-
tive and 16 negative), and 14 samples from wild-born
Bornean orangutan (Pongo pygmaeus pygmaeus; all HBsAg
negative), were provided by the Pingtung Rescue Center in
Taiwan. One male and one female lar gibbon (H. lar) from
the Welsh Mountain Zoo were also included. They were
HBsAg tested at the City Hospital, Edinburgh and the fe-
male was found to be positive whereas the male was neg-
ative.
All samples were stored at 4°C prior to shipping to the
UK according to CITES regulations, and then stored at
25°C prior to analysis.
Source of infection in HBV-positive primates
Louisa (P. troglodytes, subspecies troglodytes) was con-
fiscated in Southwest Cameroon from local people, after
which she was housed in the Limbe Wildlife Centre. Since
confiscation she has had no contact with any other primate
species. The exact details of how she was kept prior to
confiscation are unknown. The second chimpanzee was
Osang (P. troglodytes, subspecies vellerosus), and was do-
nated to a conservation project in South-Eastern Nigeria in
1996, at which time he was positive for HBsAg. Osang was
also kept by local people after he was captured, and was
subsequently kept with other chimpanzees at the conserva-
tion centre.
Of the 5 HBV-infected gibbons, 4 were wild-caught and
one was captive-born. The captive-born was a female, Ta-
mang (Hylobates lar) from a captive-born father (Paignton
Zoo) with known wild-caught parents from Malaysia and
Thailand, and a captive-born mother (Stuttgart Zoo) with
unknown parental origins. At the Welsh Zoo she is kept
with a male, Jake (H. lar) who was born at the Zoo, who
was both HBsAg and HBV PCR negative. The remaining 4
positive gibbons consist of Crazy Woman (H. agilis) con-
fiscated in Taiwan in 1993, TB Black (species not identi-
fied) confiscated in Taiwan in 1996, Happy (H. concolor
gabriellae) confiscated in Taiwan in 1996, and Wendy (H.
concolor gabriellae) confiscated in Taiwan in 1999. Their
histories prior to confiscation are unknown, as are their
origins. For the latter 4, all were HBsAg positive on first
testing after confiscation. Tamang likely acquired infection
from her mother peri- or post-natally. The subgenus and
species identifications of the HBV-infected gibbons were
provided by the sanctuary.
PCR screening and sequencing of HBV DNA
HBV sequences were amplified by PCR as previously
described (MacDonald et al., 2000) from 100 l volumes of
serum or plasma using pre-S (S1) and S (S2) gene primers
(Fig. 1A and B). Nucleotide sequencing was carried out
directly on second round amplification products using either
the Sequenase version 2.0 kit (United States Biologicals), or
ABI PRISM d-rhodamine or Big Dye kits (Applied Biosys-
tems). Positive primate samples were sequenced using over-
lapping primers covering the entire genome as described
previously (MacDonald et al., 2000) using primers S5, S3,
4, 22, 25, 26, 30, 33, 42 and the new primers 44 (5-
GTCCTTGWTGGGRTTGAAGTCCCAATC-3; positions
2959 to 2985), 45 (GGTCACMWTAYTCYTGGGAA-
CAAGA; positions 2824 to 2848), 46 (ACCAWTTTATG-
CYRCAGCCTCCTA; positions 1778 to 1801) and 47
(GGACGTCCTTTGTKTACGTCCC; positions 1415 to
1442).
For investigation of infection with possibly more diver-
gent HBV-like viruses in Old World primates, a further
PCR assay was developed using highly conserved primers
(set S3) in the surface gene that matched the following
additional sequences recovered from HBV-like viruses re-
covered from North American rodent species: K02715
(ground squirrel), NC004107 and M19183 (woodchuck)
and U29144 (arctic ground squirrel). Samples were ampli-
fied using the assay and cycling conditions as for the S1 and
S2 gene primers. Nucleotide sequences obtained in this
study have been submitted to GenBank and have been
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assigned the following accession numbers: Ay330911 to
Ay330917
Sequencing of the 12S mitochondrial region of primate
samples
Primate samples were also amplified and sequenced us-
ing primers specific for the 12S region of the mitochondria
to confirm the species and distinguish between subspecies
and individual animals to allow comparisons of the primate
and HBV phylogenies. 2 l nucleic acid was added to PCR
mix as described before and amplified using a single round
PCR reaction. Primers 12S-S (5-CCATAAACAMAYAG-
GYTTGGTCC-3; positions 641 to 664) and 12S-AS
(CAGGGTTTGCTGAAGATGGCGGTATATA; positions
1270 to 1298) were used. PCR conditions were 40 cycles of
94°C for 60 sec, 55°C for 60 sec and 72°C for 60 sec,
followed by a final extension at 72°C for 6 min. Amplified
DNA was directly sequenced using the ABI PRISM Big
Dye kit (Applied Biosystems).
Mitochondrial sequencing was used to determine the
sub-species of the 2 HBV-infected chimpanzees, from
which the following assignments were made: Osang: P.
troglodytes vellerosus, Louisa: P. troglodytes troglodytes.
Mitochondrial sequencing was unable to determine the spe-
cies for gibbon TB Black because sequences for subspecies
agilis and moloch were interspersed, and published se-
quences for gibbons were mainly determined in a different
region of the mitochondrial genome. Mitochondrial se-
quencing was also performed on samples from the previ-
ously described HBV-infected chimpanzees from whom
complete genome sequences were published [Chimp 2,
Chimp 4; (MacDonald et al., 2000) ]. Although both were
originally classified as being verus subspecies on the basis
of morphology, mitochondrial sequencing indicated that
Chimp 2 was the troglodytes subspecies; this designation
has subsequently been confirmed by the sanctuary.
Sequence analysis
Sequence data obtained using the ABI PRISM kits was
viewed using the CHROMAS sequence viewer and di-
rectly imported into the SIMMONICS sequence align-
ment program and edited. HBV sequences were aligned
with up to 10 representative sequences of each human
genotype: Genotype A—HUMPRECX, AF090839,
AF297624, E00010, HVHEPB, HEB344115, AF090838,
U87742, AF297625, AF297619; Genotype B—AY033073,
HPBA3HMS2, D50522, HPBADW3, HPBADWZ,
AF282918, HBV131133, HPBADW2, AF121249,
AF121243; Genotype C—AF233236, HHVBC, AB049610,
AF411412, HPBADRA, AF330110, AF461359, HP-
B A D R C , A F 4 1 1 4 0 8 , A F 3 6 3 9 6 4 ; G e n o t y p e
D—HEB344116, AB033559, AF280817, AF121240,
U95551, HBVAYWC, HBVAYWGEN, HBVGEN1, HB-
VORFS, HBVP6PCXX; Genotype E—HHVBE4, HHVB-
BAS; Genotype F—HBVADW4A, HHVBFFOU,
AF223965, AF223962, HHVBF, AB036910, AB036908,
AB036916 , AB036905 , AB036913 ; Geno type
G—AB056515, AF405706, AB056516, AB064312,
AB064310, AB064311, AB056514, AF160501, AB056513,
AB064313 and Genotype H—AY090454, AY090457,
AY090460. Sequences were also compared with every
available complete genome sequence obtained from pri-
mates: Chimpanzee—AB032431, HBV131575, AF242585,
AF222322, AF498266, AB046525, AF305327, AF222323,
AF242586, AB032432, HPBVCG, AB032433; Gorilla—
HBV131567; Gibbon—AY077736 , AY077735 ,
HBV131568, HBV131574, HBV131571, HBV131569,
HBU46935, HBV131572, ABO37927, AB037928; Orangu-
tan—AF193864, NC_002168 and woolly monkey—
AF046996.
Sequence comparisons in the S-gene included the following
additional further partial sequences from primates: Chimpan-
zees—AF305328, AF222318, AF222321, AF222312,
AF222319, AF222313, AF222314, AF305326, AF222316,
AF222320, AF305329, AF222317, AF305330; Gibbons—
AF213009, AF213008, AF21210, AF274495, AF274496,
AF274499, AF477482, AF477483, AF477484, AF477485,
AF477486, AF477487, AF477488, AF477489, AF477490,
AF477491, AF477492, AF477493, AF477494; Orangu-
tans—HBVY17565, HBVY17562, HBVY17559, HBVY-
17564, HBVY17561.
Phylogenetic trees for these data sets were estimated
using a maximum likelihood (ML) method. To undertake as
robust an analysis as possible, we employed the most com-
plex GTRI model of nucleotide substitution available;
this allowed each type of nucleotide change to occur at a
different rate (the general time-reversible substitution
model, GTR), a proportion of nucleotide sites to be invari-
ant (I) and a gamma () distribution of among-site rate
variation with the  shape parameter (with 4 categories)
estimated from the empirical data. The maximum likelihood
base composition was also estimated from the data. All
parameter values are available from the authors on request.
An heuristic search procedure was used to find the ML tree
using successive rounds of TBR branch-swapping, optimis-
ing the ML substitution parameters at each stage. To deter-
mine the support for key nodes on the tree we conducted a
bootstrap resampling analysis using 1000 replicate neigh-
bor-joining trees constructed under the substitution model
as defined above. All these analyses were performed using
the PAUP* package (Swofford, 1998). In all cases the
single woolly monkey sequence (AF046996) was used as an
outgroup to root the phylogenetic trees.
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